BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9131058)

  • 1. [Tumor targeting in colon cancer. Antibody therapy--a new adjuvant application].
    Chirurg; 1995 Jul; 66(7 Suppl):1-4. PubMed ID: 9131058
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adjuvant chemotherapy in colonic carcinoma?].
    Schlag P
    Dtsch Med Wochenschr; 1991 May; 116(19):755-6. PubMed ID: 2026110
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjuvant chemotherapy for colon cancer].
    Dahl O
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What's new in adjuvant therapy of colorectal cancers?].
    Louvet C
    Ann Chir; 1998; 52(6):487-90. PubMed ID: 9752495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant therapy of colon carcinoma: results of two Intergroup Studies (INT-0035 and INT-0089), a study by the German Cancer Aid 17-1A Study Group and the IMPACT Study].
    Petrasch S; Schmiegel W
    Z Gastroenterol; 1997 Jan; 35(1):49-52. PubMed ID: 9123959
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of colorectal neoplasia: clinicopathologic staging, management, and follow-up findings.
    Marks CG
    Surg Annu; 1993; 25 Pt 1():127-40. PubMed ID: 7677930
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacotherapy of colon cancer].
    Seufferlein T; V Wichert G; Adler G
    Dtsch Med Wochenschr; 2007 Sep; 132(38):1951-62. PubMed ID: 17853351
    [No Abstract]   [Full Text] [Related]  

  • 9. [Colon cancer: adjuvant chemotherapy and aftercare].
    Heinemann V; Giessen C; Modest D; Moosmann N; Stintzing S
    MMW Fortschr Med; 2011 Sep; 153(35):34-6. PubMed ID: 21916303
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cytoreductive surgery as an alternative to palliative operations in oncology (the model of treatment of stage IV colorectal cancer)].
    Grinev MV
    Vestn Khir Im I I Grek; 2002; 161(6):100-3. PubMed ID: 12638509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytoreductive surgery in the treatment of stage-IV colorectal cancer--is it justified?].
    Grinev MV; Abdusamatov FKh
    Vopr Onkol; 2000; 46(1):107-11. PubMed ID: 10789237
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
    Chua YJ; Zalcberg JR
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk stage II colon cancer after curative resection.
    Sato H; Maeda K; Sugihara K; Mochizuki H; Kotake K; Teramoto T; Kameoka S; Saito Y; Takahashi K; Hirai T; Ohue M; Shirouzu K; Sakai Y; Watanabe T; Hirata K; Hatakeyama K
    J Surg Oncol; 2011 Jul; 104(1):45-52. PubMed ID: 21416472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young age influences treatment but not outcome of colon cancer.
    Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current aspects of adjuvant and palliative chemotherapy in colorectal carcinoma].
    Bokemeyer C; Hartmann JT; Kanz L
    Praxis (Bern 1994); 1997 Sep; 86(39):1510-6. PubMed ID: 9411671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
    Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
    J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
    Kodaira S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant therapy for colon cancer].
    Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
    Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adjuvant therapeutic procedures in colorectal cancer: indications and possibilities].
    Porschen R; Bermann A
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():35-8. PubMed ID: 8197798
    [No Abstract]   [Full Text] [Related]  

  • 20. Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease.
    Damjanov N; Weiss J; Haller DG
    Oncologist; 2009 Oct; 14(10):963-9. PubMed ID: 19819916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.